US Stock MarketDetailed Quotes

BRTX Biorestorative Therapies

Watchlist
  • 1.665
  • -0.017-0.98%
Close Oct 18 16:00 ET
  • 1.600
  • -0.065-3.90%
Post 20:01 ET
11.52MMarket Cap20.81P/E (TTM)

Biorestorative Therapies Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-45.31%-1.87M
2.58%-2.32M
-8.75%-6.43M
-9.76%-1.77M
31.53%-993.95K
-2.59%-1.28M
-49.21%-2.38M
-77.58%-5.91M
-41.11%-1.62M
-130.65%-1.45M
Net income from continuing operations
29.44%-4.03M
69.00%-2.22M
21.21%-10.42M
26.77%1.17M
127.74%1.29M
-22.12%-5.71M
-48.93%-7.17M
70.16%-13.22M
104.53%924.92K
-11.27%-4.66M
Operating gains losses
-39.65%1.56M
-221.17%-1.73M
14.61%-4.57M
----
----
--2.59M
--1.42M
-133.06%-5.35M
----
----
Depreciation and amortization
14.88%47.71K
8.54%42.71K
37.49%165.74K
34.34%42.71K
34.97%42.15K
31.77%41.53K
51.29%39.35K
35.28%120.55K
47.91%31.79K
44.71%31.23K
Other non cash items
28.36%37.24K
24.30%36.06K
200.48%90.31K
-95.51%3.28K
0.00%29.01K
0.00%29.01K
113.13%29.01K
-107.07%-89.88K
-22.29%73.09K
-92.28%29.01K
Change In working capital
-31.81%192.99K
-510.09%-475.7K
3,543.42%515.33K
138.48%129.06K
266.04%181.23K
9.08%283.01K
-292.09%-77.97K
-95.64%14.14K
-54.75%-335.4K
-78.55%49.51K
-Change in receivables
184.44%7.6K
---15.7K
70.00%-3.3K
-31.03%20K
50.69%-14.3K
---9K
--0
-191.67%-11K
866.67%29K
-514.29%-29K
-Change in prepaid assets
301.03%21.1K
13.19%-60.14K
-20.86%57.85K
394.20%20.7K
533.86%116.93K
-106.33%-10.5K
33.45%-69.28K
122.10%73.1K
98.26%-7.04K
-19.12%18.45K
-Change in payables and accrued expense
-63.32%123.54K
-1,567.97%-361.08K
421.03%600.1K
144.22%124.77K
26.23%113.94K
173.91%336.8K
-86.64%24.6K
-84.53%115.18K
-233.78%-282.18K
-60.19%90.26K
-Change in other current liabilities
-16.50%-39.96K
-16.50%-38.78K
14.59%-139.33K
51.58%-36.41K
-17.03%-35.34K
-17.03%-34.3K
-17.03%-33.29K
-61.21%-163.13K
-184.36%-75.19K
-17.65%-30.19K
Cash from discontinued investing activities
Operating cash flow
-45.31%-1.87M
2.58%-2.32M
-8.75%-6.43M
-9.76%-1.77M
31.53%-993.95K
-2.59%-1.28M
-49.21%-2.38M
-77.58%-5.91M
-41.11%-1.62M
-130.65%-1.45M
Investing cash flow
Cash flow from continuing investing activities
263.01%2.97M
-294.08%-4.93M
124.27%3.25M
103.10%100.67K
97.91%-206.82K
694.91%819.03K
2,417.33%2.54M
-43,607.53%-13.4M
-10,480.11%-3.24M
-9.91M
Net PPE purchase and sale
-21.51%-35.3K
--0
35.51%-171.04K
-64.45%-70.02K
-148.56%-11.95K
78.90%-29.05K
45.22%-60.02K
-765.10%-265.22K
-38.89%-42.58K
--24.61K
Net intangibles purchase and sale
----
----
--0
----
----
----
----
---175K
----
----
Net investment purchase and sale
254.74%3.01M
-289.60%-4.93M
126.41%3.42M
105.64%170.69K
98.04%-194.87K
--848.08K
--2.6M
---12.96M
---3.03M
---9.93M
Cash from discontinued investing activities
Investing cash flow
263.01%2.97M
-294.08%-4.93M
124.27%3.25M
103.10%100.67K
97.91%-206.82K
694.91%819.03K
2,417.33%2.54M
-43,607.53%-13.4M
-10,480.11%-3.24M
---9.91M
Financing cash flow
Cash flow from continuing financing activities
-103.12%-12.84K
7.52M
2.35M
83.07K
1.85M
411.7K
0
0
0
0
Net common stock issuance
----
----
--2.35M
--83.07K
--1.85M
----
----
--0
--0
--0
Proceeds from stock option exercised by employees
--0
--7.53M
----
----
----
--0
--0
----
----
----
Net other financing activities
---12.84K
---9.54K
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-103.12%-12.84K
--7.52M
--2.35M
--83.07K
--1.85M
--411.7K
--0
--0
--0
--0
Net cash flow
Beginning cash position
-36.99%1.16M
-47.25%884.38K
-91.85%1.71M
-62.93%2.44M
-90.05%1.78M
-90.50%1.84M
-92.03%1.68M
586.11%21.03M
481.84%6.57M
919.49%17.93M
Current changes in cash
2,173.28%1.1M
70.55%272.7K
95.71%-829.4K
67.29%-1.59M
105.75%653.22K
96.20%-52.82K
109.38%159.89K
-207.52%-19.31M
-124.42%-4.86M
-1,705.09%-11.36M
End cash Position
26.27%2.25M
-36.99%1.16M
-48.40%884.38K
-48.40%884.38K
-62.93%2.44M
-90.05%1.78M
-90.50%1.84M
-91.85%1.71M
-91.85%1.71M
481.84%6.57M
Free cash flow
-44.79%-1.9M
4.98%-2.32M
-3.90%-6.6M
-0.56%-1.84M
29.51%-1.01M
5.49%-1.31M
-43.13%-2.44M
-89.06%-6.35M
-55.93%-1.83M
-126.74%-1.43M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -45.31%-1.87M2.58%-2.32M-8.75%-6.43M-9.76%-1.77M31.53%-993.95K-2.59%-1.28M-49.21%-2.38M-77.58%-5.91M-41.11%-1.62M-130.65%-1.45M
Net income from continuing operations 29.44%-4.03M69.00%-2.22M21.21%-10.42M26.77%1.17M127.74%1.29M-22.12%-5.71M-48.93%-7.17M70.16%-13.22M104.53%924.92K-11.27%-4.66M
Operating gains losses -39.65%1.56M-221.17%-1.73M14.61%-4.57M----------2.59M--1.42M-133.06%-5.35M--------
Depreciation and amortization 14.88%47.71K8.54%42.71K37.49%165.74K34.34%42.71K34.97%42.15K31.77%41.53K51.29%39.35K35.28%120.55K47.91%31.79K44.71%31.23K
Other non cash items 28.36%37.24K24.30%36.06K200.48%90.31K-95.51%3.28K0.00%29.01K0.00%29.01K113.13%29.01K-107.07%-89.88K-22.29%73.09K-92.28%29.01K
Change In working capital -31.81%192.99K-510.09%-475.7K3,543.42%515.33K138.48%129.06K266.04%181.23K9.08%283.01K-292.09%-77.97K-95.64%14.14K-54.75%-335.4K-78.55%49.51K
-Change in receivables 184.44%7.6K---15.7K70.00%-3.3K-31.03%20K50.69%-14.3K---9K--0-191.67%-11K866.67%29K-514.29%-29K
-Change in prepaid assets 301.03%21.1K13.19%-60.14K-20.86%57.85K394.20%20.7K533.86%116.93K-106.33%-10.5K33.45%-69.28K122.10%73.1K98.26%-7.04K-19.12%18.45K
-Change in payables and accrued expense -63.32%123.54K-1,567.97%-361.08K421.03%600.1K144.22%124.77K26.23%113.94K173.91%336.8K-86.64%24.6K-84.53%115.18K-233.78%-282.18K-60.19%90.26K
-Change in other current liabilities -16.50%-39.96K-16.50%-38.78K14.59%-139.33K51.58%-36.41K-17.03%-35.34K-17.03%-34.3K-17.03%-33.29K-61.21%-163.13K-184.36%-75.19K-17.65%-30.19K
Cash from discontinued investing activities
Operating cash flow -45.31%-1.87M2.58%-2.32M-8.75%-6.43M-9.76%-1.77M31.53%-993.95K-2.59%-1.28M-49.21%-2.38M-77.58%-5.91M-41.11%-1.62M-130.65%-1.45M
Investing cash flow
Cash flow from continuing investing activities 263.01%2.97M-294.08%-4.93M124.27%3.25M103.10%100.67K97.91%-206.82K694.91%819.03K2,417.33%2.54M-43,607.53%-13.4M-10,480.11%-3.24M-9.91M
Net PPE purchase and sale -21.51%-35.3K--035.51%-171.04K-64.45%-70.02K-148.56%-11.95K78.90%-29.05K45.22%-60.02K-765.10%-265.22K-38.89%-42.58K--24.61K
Net intangibles purchase and sale ----------0-------------------175K--------
Net investment purchase and sale 254.74%3.01M-289.60%-4.93M126.41%3.42M105.64%170.69K98.04%-194.87K--848.08K--2.6M---12.96M---3.03M---9.93M
Cash from discontinued investing activities
Investing cash flow 263.01%2.97M-294.08%-4.93M124.27%3.25M103.10%100.67K97.91%-206.82K694.91%819.03K2,417.33%2.54M-43,607.53%-13.4M-10,480.11%-3.24M---9.91M
Financing cash flow
Cash flow from continuing financing activities -103.12%-12.84K7.52M2.35M83.07K1.85M411.7K0000
Net common stock issuance ----------2.35M--83.07K--1.85M----------0--0--0
Proceeds from stock option exercised by employees --0--7.53M--------------0--0------------
Net other financing activities ---12.84K---9.54K--------------------------------
Cash from discontinued financing activities
Financing cash flow -103.12%-12.84K--7.52M--2.35M--83.07K--1.85M--411.7K--0--0--0--0
Net cash flow
Beginning cash position -36.99%1.16M-47.25%884.38K-91.85%1.71M-62.93%2.44M-90.05%1.78M-90.50%1.84M-92.03%1.68M586.11%21.03M481.84%6.57M919.49%17.93M
Current changes in cash 2,173.28%1.1M70.55%272.7K95.71%-829.4K67.29%-1.59M105.75%653.22K96.20%-52.82K109.38%159.89K-207.52%-19.31M-124.42%-4.86M-1,705.09%-11.36M
End cash Position 26.27%2.25M-36.99%1.16M-48.40%884.38K-48.40%884.38K-62.93%2.44M-90.05%1.78M-90.50%1.84M-91.85%1.71M-91.85%1.71M481.84%6.57M
Free cash flow -44.79%-1.9M4.98%-2.32M-3.90%-6.6M-0.56%-1.84M29.51%-1.01M5.49%-1.31M-43.13%-2.44M-89.06%-6.35M-55.93%-1.83M-126.74%-1.43M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data